Maribavir
Maribavir is listed in the FDA National Drug Code directory with 2 NDC codes. Available dosage form: powder.
Drug details
- Generic Name
- Maribavir
- Sponsor
- Ajinomoto Omnichem N.V.
- NDC Codes
- 2
- Dosage Forms
- POWDER
- Active Ingredients
- MARIBAVIR
Indications and Usage
1 INDICATIONS AND USAGE LIVTENCITY ® is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see Use in Specific Populations (8.4) and Clinical Studies (14) ] . LIVTENCITY is a cytomegalovirus (CMV) pUL97 kinase inhibitor indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet. ( 1 , 8.4 )